These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 25915825)
1. Versican upregulation in Sézary cells alters growth, motility and resistance to chemotherapy. Fujii K; Karpova MB; Asagoe K; Georgiev O; Dummer R; Urosevic-Maiwald M Leukemia; 2015 Oct; 29(10):2024-32. PubMed ID: 25915825 [TBL] [Abstract][Full Text] [Related]
2. Versican isoform V1 regulates proliferation and migration in high-grade gliomas. Onken J; Moeckel S; Leukel P; Leidgens V; Baumann F; Bogdahn U; Vollmann-Zwerenz A; Hau P J Neurooncol; 2014 Oct; 120(1):73-83. PubMed ID: 25064688 [TBL] [Abstract][Full Text] [Related]
3. Identification of tyrosine kinase, HCK, and tumor suppressor, BIN1, as potential mediators of AHI-1 oncogene in primary and transformed CTCL cells. Kennah E; Ringrose A; Zhou LL; Esmailzadeh S; Qian H; Su MW; Zhou Y; Jiang X Blood; 2009 May; 113(19):4646-55. PubMed ID: 19211505 [TBL] [Abstract][Full Text] [Related]
4. Paucity of FOXP3+ cells in skin and peripheral blood distinguishes Sézary syndrome from other cutaneous T-cell lymphomas. Klemke CD; Fritzsching B; Franz B; Kleinmann EV; Oberle N; Poenitz N; Sykora J; Banham AH; Roncador G; Kuhn A; Goerdt S; Krammer PH; Suri-Payer E Leukemia; 2006 Jun; 20(6):1123-9. PubMed ID: 16557241 [TBL] [Abstract][Full Text] [Related]
5. Transcriptome sequencing in Sezary syndrome identifies Sezary cell and mycosis fungoides-associated lncRNAs and novel transcripts. Lee CS; Ungewickell A; Bhaduri A; Qu K; Webster DE; Armstrong R; Weng WK; Aros CJ; Mah A; Chen RO; Lin M; Sundram U; Chang HY; Kretz M; Kim YH; Khavari PA Blood; 2012 Oct; 120(16):3288-97. PubMed ID: 22936659 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of c-myb in leukaemic and non-leukaemic variants of cutaneous T-cell lymphoma. Poenitz N; Simon-Ackermann J; Gratchev A; Qadoumi M; Klemke CD; Stadler R; Kremer A; Radenhausen M; Henke U; Assaf C; Utikal J; Goerdt S; Dippel E Dermatology; 2005; 211(2):84-92. PubMed ID: 16088151 [TBL] [Abstract][Full Text] [Related]
7. Versican overexpression in human breast cancer lesions: known and new isoforms for stromal tumor targeting. Kischel P; Waltregny D; Dumont B; Turtoi A; Greffe Y; Kirsch S; De Pauw E; Castronovo V Int J Cancer; 2010 Feb; 126(3):640-50. PubMed ID: 19662655 [TBL] [Abstract][Full Text] [Related]
8. Versican V1 isoform regulates cell-associated matrix formation and cell behavior differentially from aggrecan in Swarm rat chondrosarcoma cells. Wasa J; Nishida Y; Shinomura T; Isogai Z; Futamura N; Urakawa H; Arai E; Kozawa E; Tsukushi S; Ishiguro N Int J Cancer; 2012 May; 130(10):2271-81. PubMed ID: 21671478 [TBL] [Abstract][Full Text] [Related]
9. Evidence of an oncogenic role of aberrant TOX activation in cutaneous T-cell lymphoma. Huang Y; Su MW; Jiang X; Zhou Y Blood; 2015 Feb; 125(9):1435-43. PubMed ID: 25548321 [TBL] [Abstract][Full Text] [Related]
10. Isolation and characterization of calcium sensing receptor null cells: a highly malignant and drug resistant phenotype of colon cancer. Singh N; Liu G; Chakrabarty S Int J Cancer; 2013 May; 132(9):1996-2005. PubMed ID: 23055106 [TBL] [Abstract][Full Text] [Related]
11. Cancer metastasis and EGFR signaling is suppressed by amiodarone-induced versican V2. Lee HC; Su MY; Lo HC; Wu CC; Hu JR; Lo DM; Chao TY; Tsai HJ; Dai MS Oncotarget; 2015 Dec; 6(40):42976-87. PubMed ID: 26515726 [TBL] [Abstract][Full Text] [Related]
12. EPHA4 is overexpressed but not functionally active in Sézary syndrome. Hameetman L; van der Fits L; Zoutman WH; Out-Luiting JJ; Siegal G; de Esch IJ; Vermeer MH; Tensen CP Oncotarget; 2015 Oct; 6(31):31868-76. PubMed ID: 26376612 [TBL] [Abstract][Full Text] [Related]
13. The role of versican isoforms V0/V1 in glioma migration mediated by transforming growth factor-beta2. Arslan F; Bosserhoff AK; Nickl-Jockschat T; Doerfelt A; Bogdahn U; Hau P Br J Cancer; 2007 May; 96(10):1560-8. PubMed ID: 17453002 [TBL] [Abstract][Full Text] [Related]
14. The roles of versican V1 and V2 isoforms in cell proliferation and apoptosis. Sheng W; Wang G; Wang Y; Liang J; Wen J; Zheng PS; Wu Y; Lee V; Slingerland J; Dumont D; Yang BB Mol Biol Cell; 2005 Mar; 16(3):1330-40. PubMed ID: 15635104 [TBL] [Abstract][Full Text] [Related]
15. Versican G3 domain modulates breast cancer cell apoptosis: a mechanism for breast cancer cell response to chemotherapy and EGFR therapy. Du WW; Yang BB; Yang BL; Deng Z; Fang L; Shan SW; Jeyapalan Z; Zhang Y; Seth A; Yee AJ PLoS One; 2011; 6(11):e26396. PubMed ID: 22096483 [TBL] [Abstract][Full Text] [Related]
16. Role of versican V0/V1 and CD44 in the regulation of human melanoma cell behavior. Hernández D; Miquel-Serra L; Docampo MJ; Marco-Ramell A; Bassols A Int J Mol Med; 2011 Feb; 27(2):269-75. PubMed ID: 21136024 [TBL] [Abstract][Full Text] [Related]
17. Utilization of genomic signatures to identify high-efficacy candidate drugs for chemorefractory endometrial cancers. Kharma B; Baba T; Mandai M; Matsumura N; Murphy SK; Kang HS; Yamanoi K; Hamanishi J; Yamaguchi K; Yoshioka Y; Konishi I Int J Cancer; 2013 Nov; 133(9):2234-44. PubMed ID: 23595697 [TBL] [Abstract][Full Text] [Related]
19. Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer. Jiang SH; Wang Y; Yang JY; Li J; Feng MX; Wang YH; Yang XM; He P; Tian GA; Zhang XX; Li Q; Cao XY; Huo YM; Yang MW; Fu XL; Li J; Liu DJ; Dai M; Wen SY; Gu JR; Hong J; Hua R; Zhang ZG; Sun YW Oncotarget; 2016 Jan; 7(4):4226-40. PubMed ID: 26735172 [TBL] [Abstract][Full Text] [Related]
20. Overexpression of forkhead box M1 transcription factor (FOXM1) is a potential prognostic marker and enhances chemoresistance for docetaxel in gastric cancer. Okada K; Fujiwara Y; Takahashi T; Nakamura Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Mori M; Doki Y Ann Surg Oncol; 2013 Mar; 20(3):1035-43. PubMed ID: 23054116 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]